Inmunoterapia en cáncer de vejiga - page 33

And it’s not just about immune checkpoint antibodies

Cytokines

Bispecifics

Oncolytic

virus

CAR

T cells

IDO

inhibitors

Blinatumomab

approval

T-VEC

approval

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,23,24,25,26,27,28,29,30,31,32 34,35,36